However, the picture is not quite as clear for PPARδ, as an agonist of this receptor had no effect in the 6-OHDA model (Sadeghian et al., 2012), but provided neuroprotection in the MPTP-model of PD (Iwashita et al., 2007; Martin et al., 2013). This evidence concerns the gene PPARD and Parkinson disease.